Skip to main content
To KTH's start page To KTH's start page

Funding of innovations in medical research - IMI 2 Call 20

Submission deadline: 21 April 2020


Published Mar 03, 2020

In this offer within IMI - Innovative Medicines Initiative ( Funding of innovations in the field of medical research), Vinnova funds innovation projects based on research on, among other things, diagnosis, personalized treatment strategies for psoriatic arthritis, innovations to accelerate development and manufacture of vaccine, innovation and treatment for tuberculosis (UNITE4TB), tumor plasticity, proton versus photon therapy for esophageal cancer, management of protein drug products. The total budget for the call for proposal is 273 million euros. Areas that are current for funding are project tuberculosis, vaccines, esophageal cancer and protein drugs.